FACTORS AFFECTING INTENSIVE CARE AND MORTALITY IN SARS-CoV 2019 HOSPITAL PATIENTS
Backround: Information on prognosis and treatment in COVID-19 is limited and variable. We wanted to report the demographic, clinical, laboratory, radiological data and treatment and follow-up results of our patients diagnosed with COVID-19 in the study and to determine the factors affecting prognosis and mortality. Materials-methods: The study included 1161 inpatients with PCR positive and/or radiologically diagnosed COVID-19 pneumonia. Of these, 151 patients were taken to the intensive care unit and 37 patients were intubated. The data obtained through the system were evaluated retrospectively and observationally. Results: The mean age of 1161 inpatients was 54.5 years and 616 (53.1%) were male. 104 (8.9%) of 1161 inpatients died. 151 (13%) were taken to the intensive care unit. Of these, 37 (24.5%) were intubated. The analysis revealed age(p<0.001), gender(p<0.001), presence of comorbid disease (p<0.001), cough(p<0.001), shortness of breath (p<0.001), fatigue and malaise symptoms (p<0.001) and in the laboratory and signicant correlation was found with some laboratory parameters and some treatment options (p<0.001).When the living and deceased patients were compared; age (p<0.001), gender(p=0.001), presence of additional disease (p<0.001), cough(p<0.001), shortness of breath (p<0.001), malaise and fatigue symptoms (p<0.001), in the laboratory; signicant correlation was found with some laboratory parameters and some treatment options (p<0.001).Conclusion: We believe that these data obtained in our study will be important in predicting prognosis and mortality and in effective patient management. We wanted to emphasize that hydroxychloroquine, favipravir, methylprednisolone and enoxoparin are effective in reducing mortality in the treatment.